Document is current
Any future updates will be listed below
-
Authors
Sakurai, Koki https://orcid.org/0000-0001-6952-7749
Morita, Makiko
Aomine, Yoshiatsu https://orcid.org/0009-0005-1569-8207
Matsumoto, Mitsunobu
Moriyama, Tetsuji
Kasahara, Emiko https://orcid.org/0009-0002-2952-0256
Sekiyama, Atsuo
Otani, Mayumi
Oshima, Rieko
Loveland, Kate L.
Yamada, Masami
Yoneda, Yoshihiro
Oka, Masahiro https://orcid.org/0000-0003-0123-3060
Hikida, Takatoshi https://orcid.org/0000-0002-8653-311X
Miyamoto, Yoichi https://orcid.org/0000-0003-4016-1119
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP20K06455, JP22KK0111, JP15K07068, 16H04789, 16H04789, 20H03444, 23K27373, 17H03679, JP22H02944, JP23K18163)
MEXT | Japan Science and Technology Agency (JPMJSP2138, JPMJSP2138)
Japan Agency for Medical Research and Development (23ama121052, JP23ama121054, 23ama121052, JP23ama121054, JP21wm0425010, 21gm1510006)
Salt Science Research Foundation (2229)
- License Information
-
More Information
Article History
Received: 25 June 2024
Revised: 24 September 2024
Accepted: 26 September 2024
First Online: 8 October 2024
Competing interests
: MMatsumoto is a employee of Miltenyi Biotec K.K. (Tokyo, Japan). All other authors declare that no conflict of interest exists.
: All animal experiments complied with institutional guidelines by the Institutional Safety Committee on Recombinant DNA Experiments (Nos. 04219 and 04884) at Osaka University (No. 110083) and (No. DNA-420) at NIBIOHN, Animal Experimental Committee of the Institute for Protein Research at Osaka University (Nos. 29-02-1 and R04-01-1), the Animal Care and Use Committee of Kyoto University (No. MedKyo17071), and animal research committees of NIBIOHN (No. DS26-34). All animal experiments were conducted in compliance with the ARRIVE guidelines. No human subjects and materials were involved in this study.
